Aptus Capital Advisors’s AMERISAFE AMSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,500
Closed -$718K 517
2020
Q4
$718K Buy
12,500
+2,000
+19% +$116K 0.03% 212
2020
Q3
$602K Sell
10,500
-250
-2% -$15.8K 0.03% 203
2020
Q2
$657K Buy
10,750
+125
+1% +$7.78K 0.04% 170
2020
Q1
$685K Buy
10,625
+750
+8% +$49.2K 0.06% 145
2019
Q4
$652K Buy
9,875
+1,625
+20% +$108K 0.05% 225
2019
Q3
$545K Sell
8,250
-2,125
-20% -$141K 0.03% 245
2019
Q2
$661K Buy
10,375
+1,625
+19% +$97.2K 0.09% 175
2019
Q1
$519K Buy
8,750
+3,750
+75% +$223K 0.09% 170
2018
Q4
$283K Buy
+5,000
New +$312K 0.07% 95

Other funds holding AMSF

Aptus Capital Advisors's AMSF Position: Q1 2021 in Review

Aptus Capital Advisors sold out of AMERISAFE (AMSF) in Q1 2021, closing a stake of 12,500 shares — an estimated $718K sold.

Aptus Capital Advisors first reported a position in AMSF in Q4 2018 and held it in 9 quarters. The position peaked at $718K in Q4 2020. 158 funds tracked by Wall St. Rank hold AMSF as of Q1 2021.

  • Aptus Capital Advisors reported no remaining AMERISAFE position as of Q1 2021 after selling out during the quarter.
  • Aptus Capital Advisors sold 12,500 AMERISAFE shares in Q1 2021, an estimated $718K.
  • Aptus Capital Advisors first reported a position in AMERISAFE in Q4 2018 and held it in 9 quarters.
  • Aptus Capital Advisors's AMERISAFE position peaked at $718K in Q4 2020.
  • 158 funds tracked by Wall St. Rank held AMERISAFE as of Q1 2021.

Based on Aptus Capital Advisors's 13F filing for Q1 2021, filed 6 May 2021.